1. Home
  2. EB vs NMRA Comparison

EB vs NMRA Comparison

Compare EB & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eventbrite Inc.

EB

Eventbrite Inc.

HOLD

Current Price

$4.46

Market Cap

436.6M

Sector

Technology

ML Signal

HOLD

NMRA

Neumora Therapeutics Inc.

HOLD

Current Price

$2.13

Market Cap

424.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
EB
NMRA
Founded
2003
2019
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
436.6M
424.4M
IPO Year
2018
2023

Fundamental Metrics

Financial Performance
Metric
EB
NMRA
Price
$4.46
$2.13
Analyst Decision
Buy
Buy
Analyst Count
2
9
Target Price
$5.00
$8.00
AVG Volume (30 Days)
1.6M
2.4M
Earning Date
02-26-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$294,798,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.70
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.81
$0.61
52 Week High
$4.48
$3.25

Technical Indicators

Market Signals
Indicator
EB
NMRA
Relative Strength Index (RSI) 75.58 54.86
Support Level $4.45 $2.00
Resistance Level $4.48 $2.18
Average True Range (ATR) 0.02 0.20
MACD -0.04 0.01
Stochastic Oscillator 62.50 42.47

Price Performance

Historical Comparison
EB
NMRA

About EB Eventbrite Inc.

Eventbrite Inc is a self-service ticketing and experience technology platform that serves event creators. The company's two-sided marketplace connects creators and consumers every month to share their passions, artistry, and causes through live experiences. Creators use its self-service ticketing and marketing tools to plan, promote, and sell tickets to their events, and event seekers use its website and mobile application to discover and purchase tickets to experiences. Geographically, it generates maximum revenue from the United States. The company generates revenues principally from service fees and payment processing fees from the sale of paid tickets on its platform.

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

Share on Social Networks: